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Abstract A complete set of genetic tools is still
being developed for the micro-alga Chlamydomonas
reinhardtii. Yet even with this incomplete set, this
photosynthetic single-celled plant has demonstrated
signiﬁcant promise as a platform for recombinant
protein expression. In recent years, techniques have
been developed that allow for robust expression of
genes from both the nuclear and plastid genome.
With these advances, many research groups have
examined the pliability of this and other micro-algae
as biological machines capable of producing recom-
binant peptides and proteins. This review describes
recent successes in recombinant protein production in
Chlamydomonas, including production of complex
mammalian therapeutic proteins and monoclonal
antibodies at levels sufﬁcient for production at
economic parity with existing production platforms.
These advances have also shed light on the details of
algal protein production at the molecular level, and
provide insight into the next steps for optimizing
micro-algae as a useful platform for the production of
therapeutic and industrially relevant recombinant
proteins.
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Introduction
As genetically accessible photosynthetic organisms,
algae are now recognized for their potential as a
platform for recombinant protein expression where
large scale and reduced material costs are important.
The most-commonly used eukaryotic model alga,
Chlamydomonas reinhardtii, has recently been shown
to be able to ﬁll this role, and this review will
primarily discuss the technical and biological
advances made in recombinant protein production
in this alga. Algae have now come of age as a
platform for recombinant protein expression.
All three genomes (chloroplast, mitochondrial, and
nuclear) can be transformed in Chlamydomonas, and
each has distinct transcriptional, translational,
and post-translational properties that make them
distinct. Each of these genomes has been fully
sequenced, providing a wealth of information and a
strong foundation for targeted manipulation (Maul
et al. 2002; Popescu and Lee 2007; Merchant et al.
2007). Recent efforts have primarily focused on
understanding and improving gene transformation,
mRNA transcript accumulation, and protein accumu-
lation of nuclear and chloroplast recombinant genes.
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beyond its genetic and metabolic malleability. This
alga has a rapid doubling time (about 10 h), it is
easily scaled in homogenous culture as an aqueous
microbe, it can be grown either photoautotrophically
or with acetate as a reduced carbon source, and it has
a controllable and rapid sexual cycle (about 2 weeks)
with stable and viable haploids.
Advantages of algal protein production
Protein production in plants provides a number of
advantages not found in other production platforms.
First, a major advantage that all plant protein
production systems have over cell culture systems
(including bacteria, yeast, and mammalian cell cul-
ture) is the potential for signiﬁcant reduction in cost.
It is estimated that protein production in transgenic
plants can be as much as four orders of magnitude
less expensive than production in mammalian cell
culture, on a per gram of unpuriﬁed protein basis
(Dove 2002). Secondly, plant-produced proteins are
not susceptible to viral or prion contamination that
can harm humans, as is always a concern with animal
cell culture (Chebolu and Daniell 2009). Third, as
eukaryotes, algae and other plants possess the chap-
erones and cellular machinery required to fold
complex human proteins that bacteria and yeast
may not be able to process properly (Franklin and
Mayﬁeld 2004). Finally, many species of green algae
are considered GRAS (generally regarded as safe)
(Rosenberg et al. 2008), meaning that if the protein
can be expressed in a bioavailable form, puriﬁcation
steps could potentially be eliminated altogether.
Algae possess a number of advantages over
transgenic plant systems for the production of
recombinant proteins. They can be grown in con-
tained bioreactors, reducing the risk of contamination
of the production system by airborne contaminants,
and also protecting the environment from any
potential ﬂow of transgenes into the surrounding
ecosystem. Growth in containment also greatly
reduces the potential for loss of the crop due to
predation or pathogen attack. Algae progress from
initial transformation to large-scale protein produc-
tion in a matter of weeks, compared to timescales on
the order of months or years in higher plants such as
corn or tobacco (Franklin and Mayﬁeld 2004). As
micro-algae are all a single cell type, there should
also be less variation in recombinant protein accu-
mulation, making downstream processing more
uniform.
Production of recombinant proteins in chloroplasts
also possesses several unique attributes. At present
transgenic proteins can accumulate to much higher
levels in the chloroplast than when expressed from
the nuclear genome, mainly because plastids lack
gene silencing mechanisms and other mechanisms
that reduce recombinant protein production from
nuclear encoded genes (Bock 2007). Chloroplasts can
be transformed with multiple genes in a single event,
due to the availability of multiple insertion sites, as
well as an ability to process polycistronic transcripts,
allowing an entire gene cassette to be regulated by a
single promoter (Rymarquis et al. 2006; Bock 2007).
Additionally, proteins produced within the chloro-
plast are not glycosylated (Franklin and Mayﬁeld
2005), which can prove useful in many applications
such as producing antibodies that are similar to native
antibodies in their ability to recognize their antigen,
but whose lack of glycosylation prevents them from
recruiting killer cells (Tran et al. 2009). In fact, it is
estimated that over two-thirds of the therapeutic
human monoclonal antibodies in the testing pipeline
do not require glycosylation for therapeutic function
(Dove 2002).
Genetic tools and techniques
Transformation techniques
The plastid genome can be reliably transformed
through homologous recombination using bombard-
ment by DNA-coated gold or tungsten particles
(Koop et al. 2007). Nuclear transformation in algae
can also be achieved by biolistic bombardment, but
the preferred methods are electroporation or agitation
with glass beads using a cell-wall defective strain
(Eichler-Stahlberg et al. 2009; Leon and Fernandez
2007). New transformation techniques using the Cre/
lox recombination system have been demonstrated to
recombine in the nuclear genome of Chlamydomonas
(Heitzer and Zschoernig 2007). Robust in vivo
recombinant reporters, including GFPs (Fuhrmann
et al. 1999; Franklin et al. 2002) and luciferases
(Mayﬁeld and Schultz 2004; Shao and Bock 2008),
have been developed for tracking both nuclear and
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been employed previously on higher plants, such as
transformation by Agrobacterium tumefaciens, have
also been demonstrated to work with Chlamydo-
monas (Kumar et al. 2004). However, nuclear
transformants still generally fail to accumulate
recombinant proteins to the levels observed in
plastids, most likely due to nuclear silencing mech-
anisms (see Nuclear Gene Silencing below).
Codon optimization
As with other expression systems, codon optimization
has played a large role in the success of recombinant
protein expression in both the chloroplast and nuclear
genomes of Chlamydomonas (Heitzer et al. 2007).
The nuclear genome and the plastid genome have
highly divergent codon usage, with the chloroplast
preferring an A or T in the wobble position while the
nuclear genome prefers a G or C (Nakamura et al.
2000). Using GFP, early work showed that codon
optimization to reﬂect the genome bias could increase
transgene protein accumulation 5-fold in the nucleus
(Fuhrmann et al. 1999) and up to 80-fold in the
chloroplast (Franklin et al. 2002). Today, recombi-
nant genes are universally codon optimized for
improved protein expression in almost every system
(Xia 2007; Puigbo et al. 2007, 2008).
Chloroplast gene regulation
Promoter and regulatory mRNA untranslated region
(UTR) choices are both crucial factors in transgene
expression levels. In chloroplasts, the most successful
promoter to date in algae is the psbA promoter in
combination with the psbA UTRs (Manuell et al.
2007; Surzycki et al. 2009). However, there are two
caveats with using the psbA regulatory elements.
First, they appear to be highly auto-attenuated; if any
of the psbA gene product (D1 protein) is present, it
will strongly decrease expression of any recombinant
coding sequence under the control of its 50-UTR.
Secondly, since D1 is essential for the function of
photosystem II, psbA knockouts are nonphotosyn-
thetic. This would clearly negate the beneﬁts of using
a photosynthetic organism for protein production.
There is evidence that reintroducing an attenuated
psbA gene at a new locus elsewhere in the plastid
genome can restore photosynthesis while only mildly
reducing recombinant protein production (Manuell
et al. 2007).
Other UTRs in use for transgene expression
include those from the endogenous atpA, rbcL, and
psbD genes (Fletcher et al. 2007; Hallmann 2007).
These have been used with varying levels of success,
though as with the psbA promoter, it is unclear why
certain regulatory elements engender high expression
levels with some genes but not others (Marin-Navarro
et al. 2007). While endogenous promoters have been
primarily used, other exogenously induced expression
systems have been explored in the chloroplast. It has
been demonstrated that inducible systems, such as the
lac operon system from E. coli, can be engineered
into the Chlamydomonas chloroplast (Kato et al.
2007), and more recently a riboswitch was shown to
work to regulate translation in Chlamydomonas
chloroplasts using a small molecule for induction
(Croft et al. 2007), similar to their use in many other
expression platforms (Suess 2005; Winkler and
Breaker 2005).
While regulation of gene expression occurs at both
the transcriptional and translational level in the
nucleus, it appears that most regulation is post-
transcriptional in the plastid (Marin-Navarro et al.
2007). However, many of the activators and suppres-
sors of mRNA splicing and processing in the
chloroplast are indeed encoded by nuclear genes
(Boudreau et al. 2000; Somanchi et al. 2005;
Raynaud et al. 2007; Schwarz et al. 2007; Loiselay
et al. 2008). A multi-component copper-induced
system has been designed as a switch for chloroplast
protein expression. This system utilizes the nuclear-
encoded Nac2 chloroplast protein necessary for stable
accumulation of psbD RNA by acting on its
50-regulatory region. By transforming a copper
induced cytochrome c6 promoter fused to the Nac2
coding sequence into a Nac2 deﬁcient strain, proteins
encoded with the psbD regulatory region only
accumulate in the presence of copper (Surzycki
et al. 2007). Additionally, nuclear gene products are
required for splicing of group I introns in the
chloroplast 23S rRNA and psbA genes, and can
potentially be used to regulate plastid gene expres-
sion (Li et al. 2002).
Post-transcriptional control in the chloroplast is
mediated by both cis- and trans-acting-elements. The
50-UTR of chimeric chloroplast mRNAs was shown to
signiﬁcantly impact recombinant protein production,
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2005). Cis-acting elements in 30-UTRs include UG-
repeats that are used in circadian protein regulation
(Kiaulehn et al. 2007) and inverted repeat sequences
that contribute to mRNA processing (Goldschmidt-
Clermont et al. 2008). Recent work has identiﬁed a
complex comprising an RNA stabilizing factor and a
translational activator that appears to be speciﬁc to the
D2 protein of photosystem II (Schwarz et al. 2007).
Post-transcriptional control mechanisms can also have
synergistic or antagonistic effects. Kasai et al. (2003)
used the GUS reporter controlled by various endog-
enous 30- and 50-UTRs to determine that there is
an inverse correlation between protein accumulation
and transcript stability, suggesting a feedback mech-
anism. Together all of these data suggest that regu-
lation of mRNA translation has the greatest impact
on recombinant protein accumulation, and is clearly
an area where additional research seems likely to
identify mechanisms for increased recombinant pro-
tein accumulation. For a comprehensive review of
chloroplast translation regulation, see Marin-Navarro
et al. 2007.
Nuclear gene regulation
In the nucleus, the most commonly used promoters
are those from the HSP70A, psaD, and rbcS2 genes
(Schroda et al. 2002; Fischer and Rochaix 2001;
Berthold et al. 2002). Chimeric promoters have also
demonstrated high levels of transcription and expres-
sion (Schroda et al. 2000; Fischer and Rochaix 2001;
Wu et al. 2008). Additionally, placing endogenous
intronic sequences in transgenes has been shown to
enhance expression regardless of orientation or
position. The ﬁrst intron from the endogenous rbcS2
gene has shown particular efﬁcacy in increasing
mRNA and protein accumulation and is now com-
monly used to enhance recombinant gene expression
(Lumbreras et al. 1998).
In the nucleus, gene expression can be induced by
a number of factors, including heat-shock or metal
addition (Wu et al. 2008; Ferrante et al. 2008). The
Nit1 promoter suppresses transcription in the pres-
ence of ammonia, but induces transcription when
cells are grown in nitrate- or nitrite-containing media
(Ohresser et al. 1997). More recently, iron-deﬁciency
response elements (FeREs) in nuclear gene promoters
have been characterized in Chlamydomonas (Fei and
Deng 2007). Signaling cascades triggered by photo-
oxidative stress in the chloroplast can also activate
transcription of speciﬁc nuclear genes, indicating that
gene regulation in Chlamydomonas is not necessarily
localized to the site of signal production (Fischer
et al. 2007). More recently, signaling molecules such
as Mg-protoporphyrin and heme produced in the
plastid have been shown to activate transcription of
nuclear genes such as HSP70A through an interac-
tion with the plastid response element (PRE) (von
Gromoff et al. 2008). While these inducible systems
provide great insight into gene regulatory strategies,
there is still signiﬁcant work to be done before robust
production of recombinant proteins can be routinely
achieved from nuclear genes in algae.
Nuclear gene silencing
Transgene silencing is a signiﬁcant obstacle for
recombinant protein expression in Chlamydomonas
nuclear transformants, but recent work is helping to
overcome this problem (Casas-Mollano et al. 2007,
2008a, b). Neupert et al. (2009) have developed
strains with impaired transgene silencing by using
UV mutagenesis and selection on media that permits
higher antibiotic tolerance proportional to higher
expression of the transgene product, to select strains
with improved protein accumulation. However, their
most impressive yields of exogenous protein accu-
mulation are only 0.2% of total soluble protein (TSP),
as compared to nearly 10% TSP obtained in plastids
(Manuell et al. 2007). It has been postulated that gene
silencing may be difﬁcult to eliminate because it may
have evolved as a protective measure against intra-
cellular pathogens or viruses (Rosenberg et al. 2008;
Neupert et al. 2009). It appears that combating gene
silencing will be a major hurdle before recombinant
proteins can be expressed at economically viable
levels from nuclear transgenes in Chlamydomonas.
Current successes in algal protein production
Plastid transformation in higher plants has identiﬁed a
few recombinant proteins that accumulate to very
high levels, reported up to as high as 70% of total
protein for some antibiotic proteins in tobacco leaves
(Oey et al. 2009), but in general recombinant protein
expression is highly variable. For an extensive review
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omi et al. (2009). However, very recent work in
Chlamydomonas has demonstrated that fully bioac-
tive proteins can indeed be produced to appreciable
levels in green algae. A recent technique has been
exploited to improve protein accumulation and sta-
bility by expression of cleavable fusions to highly
expressed endogenous proteins (Muto et al. 2009), or
to highly expressed recombinant proteins in the
chloroplast (Rasala et al. 2010).
The ﬁrst demonstration of mammalian protein
expression in the chloroplast was of a large single-
chain antibody (HSV8-lsc) directed against glyco-
protein D of the herpes simplex virus (Mayﬁeld et al.
2003). The protein was soluble, suggesting that it was
correctly folded, and electrophoresis indicated the
formation of the dimer by disulﬁde bond formation.
This work was followed up by the expression of a
single chain fragment variable antibody that accu-
mulated to 0.54% TSP (Mayﬁeld and Franklin 2005).
More recently a full-length human IgG1 monoclonal
antibody, directed against anthrax protective antigen
83 (83K7C), was expressed in the chloroplast of
Chlamydomonas (Tran et al. 2009). Unlike the
previously expressed lsc antibody, this antibody was
assembled in the chloroplast from separately
expressed light chain and heavy chain proteins, and
it could be puriﬁed at 100 lg per 1 g dry algal
biomass, and was found to have binding activity
identical to that of the same antibody expressed in a
traditional mammalian cell culture system (Tran et al.
2009).
A host of non-antibody recombinant proteins have
been expressed in the chloroplast for therapeutic
purposes. The human metallothionein-2 gene prod-
uct, which is considered to have anti-radiation
function, was expressed and demonstrated to improve
the survivorship of transgenic algae compared to wild
type algae (Zhang et al. 2006). The human tumor
necrosis factor-related apoptosis-inducing ligand
(TRAIL) protein, known to induce apoptosis in
virus-infected and tumor cells, accumulated in the
chloroplast at 0.43–0.67% TSP based on densitomet-
ric analysis of Western blot (Yang et al. 2006). The
expression of human glutamic acid decarboxylase
(hGAD65) was also achieved in the chloroplast of
Chlamydomonas (Wang et al. 2008). This protein
is an important autoantigenic marker in type I
diabetes, and the algae-derived protein remained
immunologically active, accumulating at 0.25–0.3%
TSP. Human erythropoietin (Epo), used in the
treatment of anemia, was fused to an export sequence
and expressed from the nuclear genome (Eichler-
Stahlberg et al. 2009). Protein was detected in and
isolated from the culture medium, although with
uncharacterized post-translational modiﬁcation clo-
sely matching the mass of endogenous human Epo.
Also, biologically active bovine mammary-associated
serum amyloid (M-SAA) was expressed in the
chloroplast (Manuell et al. 2007). Notably, the
accumulation of this soluble protein was above 5%
TSP as quantiﬁed by Western blot, with levels of
expression determined to be more than twice that
amount using ELISA quantiﬁcation.
A fusion protein containing the foot-and-mouth
disease virus VP1 gene and the cholera toxin B
subunit (CTBVP1) was produced in the chloroplast as
well (Sun et al. 2003). The protein was reported to
accumulate to 3% total protein by ELISA quantiﬁ-
cation, and retained GM1-ganglioside binding activ-
ity and antigenicity. Another viral protein, classical
swine fever virus E2 structural protein, was expressed
in the chloroplast (He et al. 2007). ELISA quantiﬁ-
cation indicated the accumulation of the E2 protein to
1.5–2% TSP, and retained immunological activity.
Similarly, along with a list of other recombinant
proteins, the white spot syndrome virus protein 28
(VP28) was expressed in the chloroplast (Surzycki
et al. 2009). VP28 was reported to accumulate to a
striking 10.5% TSP, although no data was presented
to show how this level of expression was determined.
Recently, the D2 ﬁbronectin-binding domain from a
Staphylococcus aureus protein was fused to the B
subunit of cholera toxin, and expressed in the
chloroplast (Dreesen et al. 2010). The transgenic
algae were fed to mice, and induced resistance
against lethal doses of S. aureus, presumably by
eliciting a systemic antigenic response to the
S. aureus peptide. This is the ﬁrst demonstration of
the functional possibility of orally delivered vaccines
from algal production.
More recently, Rasala et al. (2010) attempted the
expression of a set of seven recombinant proteins in
the chloroplast and were met with very good success
(four out of the seven genes expressed at economi-
cally viable levels). This work demonstrates that
recombinant protein expression in algal chloroplasts
is on par with any other expression platform, and
Biotechnol Lett (2010) 32:1373–1383 1377
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teins is as likely to be achieved in algae as it is in any
eukaryotic system. These data are summarized in
Table 1.
Potential future applications
Oral vaccines
Traditional vaccines are normally produced from an
attenuated or killed form of the pathogenic organism
itself. An alternative approach is to produce a
pathogen antigen as a recombinant protein, and this
is now used for some select vaccines like the hepatitis
A vaccine (Powdrill and Johnston 1991). As algae
contain very sophisticated protein folding machinery
that bacteria and other prokaryotes lack, algae can be
used to produce complex eukaryotic proteins that
cannot be easily produced on large scale in bacterial
culture without costly denaturation and refolding
steps. Algae are also ideal for producing vaccines
against pathogens which exhibit little or no glyco-
sylation, such as those from the parasites plasmodium
(Gowda and Davidson 1999).
Algae are also especially suited for the production
of oral vaccines on a large scale due to their GRAS
status. Once the process of oral delivery of a vaccine
protein is reﬁned, algae could produce inexpensive
oral vaccines, making vaccination an accessible form
of disease management for a whole host of third-
world diseases. Furthermore, the oral delivery
method and the option to store doses at ambient
temperature would allow vaccines to be transported
and administered to remote populations without the
need for expensive refrigeration or highly trained
medical personnel (Chebolu and Daniell 2009).
Evidence for the feasibility of plastid-produced
vaccines has been provided by several groups who
have produced antigens that elicit similar immune
responses as the actual pathogen when injected in
standard vaccine adjuvants (Tregoning et al. 2003;
Koya et al. 2005; Molina and Shoenfeld 2005;
Chebolu and Daniell 2009). Furthermore, fusions of
antigens with the cholera toxin B subunit show
promise for eliciting immune response from mucosal
delivery alone, as the cholera toxin B subunit allows
a fused protein to penetrate the intestinal lining
(Sun et al. 2003; Harakuni et al. 2005).
Discovery of novel bioactive molecules
Screening of diverse algal species for novel bioactive
compounds has become a ﬁeld of intense interest
lately, as algae are a rich source of secondary
metabolites that often have industrial or nutritional
implications. A wide range of functional molecules
produced by algae—everything from antioxidants to
pigments used in laboratory analytical techniques—
have been isolated (Plaza et al. 2009). High-through-
put screening methods comprising pressurized liquid
extraction; functional characterization of antioxidant
or antimicrobial activity; and chemical characteriza-
tion by HPLC and GC-MS have been optimized to
streamline the screening process (Plaza et al. 2010).
Protein secretion
Figure 1 illustrates the basic structure of Chlamydo-
monas reinhardtii, as well as the cellular locations of
recombinant protein accumulation depending on the
gene construct and transformation method. Plastid
transformation results in accumulation of the trans-
gene product in the single large chloroplast. Nuclear
gene products accumulate in the cytosol by default,
but nuclear transformation with appropriate signal
sequences allows for targeting to the endoplasmic
reticulum and Golgi for export (Griesbeck et al.
2006) or for localization to the cell membrane, which
may be sufﬁcient for antigenic recognition in the case
of an oral vaccine (Eichler-Stahlberg et al. 2009).
Other algal transformation efforts
Genetic manipulation of algae is no longer limited to
Chlamydomonas reinhardtii. Recent successes in
generating transgenic algae are growing in number.
Exogenous genes have been expressed in the unicel-
lular charophyte alga, Closterium peracerosum–strig-
osum–littorale complex (Abe et al. 2008). The nuclear
genome of volvocine alga Gonium pectorale has been
stably transformed (Lerche and Hallmann 2009),
as has the chlorophyceae Haematococcus pluvialis
(Kathiresan and Sarada 2009), by co-cultivation with
Agrobacterium (Kathiresan et al. 2009). Some suc-
cesses have been made by transient transformation of
marine chlorarachniophyte Lotharella amoebiformis
(Hirakawa et al. 2008), chlorophyta alga Ulva pertusa
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123(Kakinuma et al. 2009), and red alga Cyanidioschyzon
merolae (Ohnuma et al. 2008). Methods have also
been improved for previously transformed alga, such
as Dunaliella salina (Feng et al. 2009), and cyano-
bacterial genetics have also been extensively
explored, but will not be discussed in this review.
Future challenges
A signiﬁcant obstacle for algal protein expression
systems is the lack of production systems optimized
for large-scale growth and harvesting of algae under
photoautotrophic conditions. The main limitations
in photobioreactor size arise from inhibited gas
exchange and light penetration in large cultures,
especially at the high cell densities required to keep
costs low (Ugwu et al. 2008). An alternative
approach, which has been discussed extensively by
Chen and Chen (2006), is to grow algae heterotro-
phically in conventional fermentation bioreactors.
This is certainly an economically viable option for
high-value products such as therapeutics or enzymes,
and indeed is currently used in much of the micro-
algae products industry (Chen and Chen 2006) with
yields reported as high as 83 g dry weight per liter of
culture for some species (de Swaaf et al. 2003).
Maximum yields for Chlamydomonas reinhardtii are
around 1.5 g dry biomass per liter when grown in
continuous ﬂow on acetate media (Chen and Johns
1996).
The scale and cost requirements for algal biofuels
will likely necessitate photoautotrophic open cultiva-
tion systems. These systems are being improved, as
are processes for efﬁciently harvesting the algae. For
example, new methods have been optimized for
harvesting algae using microbes capable of ﬂoccu-
lating 90% of the algal mass with no deleterious
effect on algal viability (Lee et al. 2009). More
efﬁcient methods and systems for large-scale growth
are critical if algal-derived biofuels are to become a
reality. If these issues can be resolved, algae repre-
sent a far superior source of biofuel than terrestrial
plants. It is estimated algae can produce up to ten
times as much oil per acre than any current terrestrial
crop (Cooney et al. 2009). For a detailed recent
review on the potential of algal biofuels, see Mata
et al. 2010.
Conclusion
Several decades of work in Chlamydomonas has
elucidated a better understanding of the transcrip-
tional and translational machinery and regulation of
the cell, ultimately generating improved methods for
transgenic expression of recombinant proteins in
algae. However, only in the past few years have these
advances been used to successfully express large,
fully bioactive, therapeutically relevant proteins at a
level sufﬁcient for economically viable large-scale
production. Extensive research on optimal transfor-
mation constructs and gene optimization have greatly
increased yields of recombinant protein, though
further work is still needed to address nuclear gene
Fig. 1 Chlamydomonas reinhardtii as a versatile recombinant
protein production platform. Protein expressed from the
chloroplast genome is accumulated inside the single large
chloroplast (a). The reducing environment of the chloroplast
allows for proper folding of heavily disulﬁde bonded proteins,
which is not easily accomplished in bacterial production
platforms. Protein expressed from the nuclear genome accumu-
lates in the cytosol (b), unless it is given an export signal
sequence. In this case, it is sent to the endoplasmic reticulum for
translocation and processing and then moves to the Golgi
apparatusforpackagingandexporttotheextracellularmedia(c)
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123silencing, plastid auto-attenuation, and to optimize
reactor design for large-scale use. Algae have proven
their utility and tractability as a production system for
therapeutic or industrial proteins and peptides, and
algae now seem poised to become the ‘‘green’’
alternative to current mammalian, yeast, or bacterial
recombinant protein production systems.
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